Literature DB >> 19657862

Comparison of [18F]FDG uptake and distribution with hypoxia and proliferation in FaDu human squamous cell carcinoma (hSCC) xenografts after single dose irradiation.

Kerstin Bruechner1, Ralf Bergmann, Alina Santiago, Birgit Mosch, Ala Yaromina, Franziska Hessel, Frank Hofheinz, Joerg van den Hoff, Michael Baumann, Bettina Beuthien-Baumann.   

Abstract

PURPOSE: This study investigated the uptake of [(18)F]2-fluoro-2-deoxy-glucose ([(18)F]FDG) in the human tumour xenograft FaDu at early time points after single dose irradiation with Positron-Emission-Tomography (PET), autoradiography and functional histology.
MATERIALS AND METHODS: [(18)F]FDG-PET of FaDu hSCC xenografts on nude mice was performed before 25 Gy or 35 Gy single dose irradiation and one, seven or 11 days post irradiation (p.irr.). Before the second PET, mice were injected with pimonidazole (pimo) and bromodeoxyuridine (BrdU). After the PET tumours were excised, sliced and subjected to autoradiography and functional histology staining (pimo, BrdU, Ki67). [(18)F]FDG tumour uptake was quantified in the PET scans by maximal standard uptake value (SUV(max)) and in the autoradiography after co-registration to the histology slices.
RESULTS: No differences in the overall [(18)F]FDG uptake between the two dose groups and time points were found with PET or autoradiography. Comparing autoradiography and histology, the [(18)F]FDG uptake was constant in tumour necrosis over time, while it decreased in vital tumour areas and particularly in hypoxic regions. No differences in the [(18)F]FDG uptake between positive and negative areas of Ki67 and BrdU were found.
CONCLUSIONS: The decline of [(18)F]FDG uptake in vital tumour and in pimopositive areas as seen in autoradiography, was not reflected by evaluation of SUV(max) determined by PET. These findings suggest that the SUV(max) does not necessarily reflect changes in tumour biology after irradiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19657862     DOI: 10.1080/09553000903043067

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  7 in total

Review 1.  Individualization of cancer treatment from radiotherapy perspective.

Authors:  Ala Yaromina; Mechthild Krause; Michael Baumann
Journal:  Mol Oncol       Date:  2012-02-09       Impact factor: 6.603

2.  Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer.

Authors:  Maria Hentschel; Steffen Appold; Andreas Schreiber; Nasreddin Abolmaali; Andrij Abramyuk; Wolfgang Dörr; Joerg Kotzerke; Michael Baumann; Klaus Zöphel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02-25       Impact factor: 9.236

3.  PEGylated IL-11 (BBT-059): A Novel Radiation Countermeasure for Hematopoietic Acute Radiation Syndrome.

Authors:  Vidya P Kumar; Shukla Biswas; Neel K Sharma; Sasha Stone; Christine M Fam; George N Cox; Sanchita P Ghosh
Journal:  Health Phys       Date:  2018-07       Impact factor: 1.316

Review 4.  Validation of functional imaging as a biomarker for radiation treatment response.

Authors:  C Jentsch; B Beuthien-Baumann; E G C Troost; G Shakirin
Journal:  Br J Radiol       Date:  2015-05-29       Impact factor: 3.039

5.  Utility of 3'-[(18)F]fluoro-3'-deoxythymidine as a PET tracer to monitor response to gene therapy in a xenograft model of head and neck carcinoma.

Authors:  Neale S Mason; Brian J Lopresti; James Ruszkiewicz; Xinxin Dong; Sonali Joyce; George Leef; Malabika Sen; Abdus S Wahed; Chester A Mathis; Jennifer R Grandis; Sufi M Thomas
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-01-05

6.  Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy.

Authors:  Roberta Aliperta; Petra B Welzel; Ralf Bergmann; Uwe Freudenberg; Nicole Berndt; Anja Feldmann; Claudia Arndt; Stefanie Koristka; Marcello Stanzione; Marc Cartellieri; Armin Ehninger; Gerhard Ehninger; Carsten Werner; Jens Pietzsch; Jörg Steinbach; Martin Bornhäuser; Michael P Bachmann
Journal:  Sci Rep       Date:  2017-02-16       Impact factor: 4.379

7.  Bridging from Brain to Tumor Imaging: (S)-(-)- and (R)-(+)-[18F]Fluspidine for Investigation of Sigma-1 Receptors in Tumor-Bearing Mice.

Authors:  Mathias Kranz; Ralf Bergmann; Torsten Kniess; Birgit Belter; Christin Neuber; Zhengxin Cai; Gang Deng; Steffen Fischer; Jiangbing Zhou; Yiyun Huang; Peter Brust; Winnie Deuther-Conrad; Jens Pietzsch
Journal:  Molecules       Date:  2018-03-20       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.